Basket

  Untick selected:   0
  1. Gemcitabine, carboplatin and veliparib in multiple relapsed/refractory germ cell tumours: The GCT-SK-004 phase II trial  / Mego M. ... [et al.] .  Onkológia. - ISSN 1336-8176 . - Roč. 16, č. 3 (2021), s. 231  
    C 3069
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.